Clinical Trial Transparency

The People You Trust. The Software You Need. Anonymize to Power Innovation.

transparency_icon_white
 
 
 

Clinical Trial Transparency for Data & Document Disclosure

Health Canada, EMA Policy 0070, and research sharing shape sponsors' timelines and risk tolerance. Create a unified, reproducible approach to safeguard the sharing of data and documents.

High Utility Sharing to Power Medical Innovation
  • 6 +
    Health Canada PRCI Submissions
  • 30 +
    Policy 070 Submissions
  • 365 +
    Datsets De-Identified
  • 532 +
    Documents Anonymized

Products and Services Overview

Data and document strategy, automation, process improvement, and software.

  • Service csce

    De-Identification Services

    Outsource de-identification of data and documents to experts with proven processes and tools. Keeps patient information private and your organization productive with a range of services, that conveniently outsource redaction, anonymization, and quantifiable risk measurement.

    Learn More

  • Product csce

    Blur

    Built by collaborating with global Life Sciences, Blur was solely designed to automate the sharing process at Sponsors. With an integrated workflow process, flexible controls, and advanced automation features, Blur has become the #1 most used tool for anonymization and quantifiable risk measurement.

    Learn More

  • Service Strategy: Clinical data and document privacy

    Transparency Strategy

    Strategy and plans to enhance your organization's sharing capabilities.

    Experts in Health Canada- PRCI, Policy 070, our transparency leaders educate, create business processes, and lead change management at sponsors as they move to data and document anonymization and quantifiable risk measurement. 

    Learn More